519 related articles for article (PubMed ID: 33036570)
41. Prevalence of Gastrointestinal Symptoms and Fecal Viral Shedding in Patients With Coronavirus Disease 2019: A Systematic Review and Meta-analysis.
Parasa S; Desai M; Thoguluva Chandrasekar V; Patel HK; Kennedy KF; Roesch T; Spadaccini M; Colombo M; Gabbiadini R; Artifon ELA; Repici A; Sharma P
JAMA Netw Open; 2020 Jun; 3(6):e2011335. PubMed ID: 32525549
[TBL] [Abstract][Full Text] [Related]
42. Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review.
Nussbaumer-Streit B; Mayr V; Dobrescu AI; Chapman A; Persad E; Klerings I; Wagner G; Siebert U; Ledinger D; Zachariah C; Gartlehner G
Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013574. PubMed ID: 33959956
[TBL] [Abstract][Full Text] [Related]
43. Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial.
González R; García-Otero L; Pons-Duran C; Marbán-Castro E; Goncé A; Llurba E; Gil MDM; Rodríguez-Zambrano MÁ; Chen H; Ramírez M; Bardají A; Menendez C
Trials; 2020 Jul; 21(1):607. PubMed ID: 32616063
[TBL] [Abstract][Full Text] [Related]
44. Can Air-Conditioning Systems Contribute to the Spread of SARS/MERS/COVID-19 Infection? Insights from a Rapid Review of the Literature.
Chirico F; Sacco A; Bragazzi NL; Magnavita N
Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32825303
[TBL] [Abstract][Full Text] [Related]
45. Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID-19: initial assessment.
Ford N; Vitoria M; Rangaraj A; Norris SL; Calmy A; Doherty M
J Int AIDS Soc; 2020 Apr; 23(4):e25489. PubMed ID: 32293807
[TBL] [Abstract][Full Text] [Related]
46. Two Pandemics, One Challenge-Leveraging Molecular Test Capacity of Tuberculosis Laboratories for Rapid COVID-19 Case-Finding.
Homolka S; Paulowski L; Andres S; Hillemann D; Jou R; Günther G; Claassens M; Kuhns M; Niemann S; Maurer FP
Emerg Infect Dis; 2020 Nov; 26(11):2549-2554. PubMed ID: 32956612
[TBL] [Abstract][Full Text] [Related]
47. From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses.
Zhu Z; Lian X; Su X; Wu W; Marraro GA; Zeng Y
Respir Res; 2020 Aug; 21(1):224. PubMed ID: 32854739
[TBL] [Abstract][Full Text] [Related]
48. COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study.
Garassino MC; Whisenant JG; Huang LC; Trama A; Torri V; Agustoni F; Baena J; Banna G; Berardi R; Bettini AC; Bria E; Brighenti M; Cadranel J; De Toma A; Chini C; Cortellini A; Felip E; Finocchiaro G; Garrido P; Genova C; Giusti R; Gregorc V; Grossi F; Grosso F; Intagliata S; La Verde N; Liu SV; Mazieres J; Mercadante E; Michielin O; Minuti G; Moro-Sibilot D; Pasello G; Passaro A; Scotti V; Solli P; Stroppa E; Tiseo M; Viscardi G; Voltolini L; Wu YL; Zai S; Pancaldi V; Dingemans AM; Van Meerbeeck J; Barlesi F; Wakelee H; Peters S; Horn L;
Lancet Oncol; 2020 Jul; 21(7):914-922. PubMed ID: 32539942
[TBL] [Abstract][Full Text] [Related]
49. Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis.
Alqahtani JS; Oyelade T; Aldhahir AM; Alghamdi SM; Almehmadi M; Alqahtani AS; Quaderi S; Mandal S; Hurst JR
PLoS One; 2020; 15(5):e0233147. PubMed ID: 32392262
[TBL] [Abstract][Full Text] [Related]
50. Severe Coronavirus Infections in Pregnancy: A Systematic Review.
Galang RR; Chang K; Strid P; Snead MC; Woodworth KR; House LD; Perez M; Barfield WD; Meaney-Delman D; Jamieson DJ; Shapiro-Mendoza CK; Ellington SR
Obstet Gynecol; 2020 Aug; 136(2):262-272. PubMed ID: 32544146
[TBL] [Abstract][Full Text] [Related]
51. nCoV-2019 infection induced neurological outcome and manifestation, linking its historical ancestor SARS-CoV and MERS-CoV: a systematic review and meta-analysis.
Prakash A; Singh H; Sarma P; Bhattacharyya A; Dhibar DP; Balaini N; Shree R; Goyal M; Modi M; Medhi B
Sci Rep; 2021 Jun; 11(1):12888. PubMed ID: 34145351
[TBL] [Abstract][Full Text] [Related]
52. Patients hospitalized with active tuberculosis and Covid-19 coinfection: A matched case-control from the Brazilian Covid-19 Registry.
Carvalho RLR; Aguiar GG; Moreira JFB; Pereira DN; Augusto VM; Schwarzbold AV; Matos CC; Rios DRA; Costa FR; Anschau F; Chatkin JM; Ruschel KB; Carneiro M; Oliveira NR; Paraíso PG; Aguiar RLO; Grizende GMS; Marcolino MS
An Acad Bras Cienc; 2024; 96(1):e20230791. PubMed ID: 38656058
[TBL] [Abstract][Full Text] [Related]
53. Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis.
Kumar A; Arora A; Sharma P; Anikhindi SA; Bansal N; Singla V; Khare S; Srivastava A
Diabetes Metab Syndr; 2020; 14(4):535-545. PubMed ID: 32408118
[TBL] [Abstract][Full Text] [Related]
54. Tuberculosis-Human Immunodeficiency Virus (HIV) co-infection in Ethiopia: a systematic review and meta-analysis.
Teweldemedhin M; Asres N; Gebreyesus H; Asgedom SW
BMC Infect Dis; 2018 Dec; 18(1):676. PubMed ID: 30563476
[TBL] [Abstract][Full Text] [Related]
55. Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) co-infection with HIV: clinical case series analysis in North Central Nigeria.
Akyala AI; Iwu CJ
Pan Afr Med J; 2020; 37():47. PubMed ID: 33209174
[TBL] [Abstract][Full Text] [Related]
56. Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents?
Lai CC; Wang CY; Hsueh PR
J Microbiol Immunol Infect; 2020 Aug; 53(4):505-512. PubMed ID: 32482366
[TBL] [Abstract][Full Text] [Related]
57. A systematic review and meta-analysis of the use of renin-angiotensin system drugs and COVID-19 clinical outcomes: What is the evidence so far?
Kurdi A; Abutheraa N; Akil L; Godman B
Pharmacol Res Perspect; 2020 Dec; 8(6):e00666. PubMed ID: 33084232
[TBL] [Abstract][Full Text] [Related]
58. Interventions to support the resilience and mental health of frontline health and social care professionals during and after a disease outbreak, epidemic or pandemic: a mixed methods systematic review.
Pollock A; Campbell P; Cheyne J; Cowie J; Davis B; McCallum J; McGill K; Elders A; Hagen S; McClurg D; Torrens C; Maxwell M
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD013779. PubMed ID: 33150970
[TBL] [Abstract][Full Text] [Related]
59. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
60. The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status.
Bchetnia M; Girard C; Duchaine C; Laprise C
J Infect Public Health; 2020 Nov; 13(11):1601-1610. PubMed ID: 32778421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
